Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Bromfenac (0.9mg) Eye Drop
Therapeutic Category
Ophthalmology
Dosage Form
Eye Drops
Packaging Type
Dropper
Packaging
5ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Catabro Eye Drop (Bromfenac 0.9mg) is a high-profit, essential surgical care product built for our PCD Pharma Franchise partners.
As a powerful, twice-daily Non-Steroidal Anti-Inflammatory Drug (NSAID), Bromfenac is widely prescribed by ophthalmologists to manage inflammation and pain following common procedures like cataract surgery. This guarantees stable, high-volume demand directly linked to surgical rates.
Why Catabro is Your Key to Profit:
Stable, High-Volume Demand: With the high frequency of cataract and other anterior segment surgeries, the need for post-operative pain and inflammation management is constant, ensuring consistent, recurring revenue.
Excellent Specialty Margin: Positioned as an essential drug in the high-value ophthalmic specialty segment, this product commands superior pricing and secures some of the highest profit margins in eye care.
Surgeon Loyalty: The proven efficacy and safety profile of Bromfenac ensure its position as a primary choice for surgeons, building strong, reliable prescription loyalty.
Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition in your designated specialty clinics and hospitals. Partner with us for full marketing support to secure high-value prescriptions and guaranteed business growth.
Contact us today to capture this high-margin surgical segment!
Common side effects may include mild burning, stinging, or temporary blurred vision after instillation. Rarely, patients may experience eye redness, itching, or allergic reactions. If severe pain, swelling, or vision changes occur, seek immediate medical attention.
Catabro Eye Drop is indicated for the treatment of ocular inflammation and pain, often used after cataract surgery or other ocular procedures. It helps reduce swelling, redness, and discomfort associated with post-operative inflammation or other inflammatory eye conditions.
Use Catabro Eye Drop exactly as prescribed by your ophthalmologist. Do not touch the dropper tip to the eye or any surface to prevent contamination. Remove contact lenses before application and wait at least 15 minutes before reinserting them. Inform your doctor if you have a history of ocular ulcers, hypersensitivity to NSAIDs, or other eye conditions.
Store Catabro Eye Drop in a cool, dry place below 25°C, away from direct sunlight. Keep the bottle tightly closed and out of reach of children. Once opened, use within 4 weeks, and discard any remaining solution.
Composition : Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v) Eye Drops
Composition : Atropine Sulphate IP 1% w/v + Stabilized Oxychloro complex 0.005% w/v
Composition : Brimonidine Tartrate IP 0.2% w/v Eye Drop
Composition : Bromfenac (0.9mg) Eye Drop
Composition : Carboxymethycellulose Sodium IP 0.3%w/v + N-Acetyl Carnosine 1% w/v + Glycerin IP 1% w/v + Boric Acid IP 0.1% w/v + Benzyl Alcohol IP 0.1%W/V
Composition : Bromfenac (0.09% w/v) + Moxifloxacin (0.5% w/v)
Composition : Bromfenac (0.9mg) Eye Drops
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This ophthalmic formulation has steady demand in the eye inflammation and post-operative care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on ophthalmology portfolios.
Medical distributors and agencies can benefit from consistent demand for management of eye pain, redness, swelling, and post-surgical inflammation (especially after cataract surgery). Bromfenac is a non-steroidal anti-inflammatory drug (NSAID) that reduces ocular inflammation and pain Benzalkonium chloride acts as a preservative to maintain formulation stability This supports a reliable ophthalmology post-operative care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this eye drop with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong ophthalmologist prescriptions, post-cataract surgery demand, steady hospital usage, reliable supply chain support, and good margins in eye-care medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, territory rights, and distribution opportunities.